lifestyle.smarttalksuccess.com

Author: Business Wire

DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer

December 22, 2025
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor

December 22, 2025
JAB Insurance to Enter UK Life and Pension Market With Acquisition of Utmost Group’s Life and Pensions Business

December 22, 2025
Coty Appoints Markus Strobel Executive Chairman and Interim CEO

December 22, 2025
Mitsubishi Electric Invests in Tulip Interfaces And Signs Strategic Alliance Agreement

December 22, 2025
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025

December 22, 2025
GenSight Biologics Announces the Granting of Compassionate Use Authorization (CUA/AAC) for GS010/LUMEVOQ® in France

December 22, 2025
e.l.f. Cosmetics Extends Partnership with The Wonder Women of Wrestling Foundation

December 22, 2025
QAD | Redzone Marks 20 Years in India by Honoring 2025 Champions of Change Driving the Future of Manufacturing

December 21, 2025
Hisense Joins HEVC Advance Patent Pool

December 21, 2025